Dechert survey: Developments in securities fraud class actions against U.S. life sciences companies

February 17, 2017
2016 Edition

Life sciences companies continued to be popular targets of securities fraud class action lawsuits filed in 2016, and prudent life sciences companies should take heed of the results of this year's decisions.

Read the full article here.

Subscribe to Dechert Updates